Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | FABP4 | P15090 | 5/20 | 0.62 |
| ▸ | FABP3 | P05413 | 4/20 | 0.59 |
| ▸ | FTO | Q9C0B1 | 2/20 | 0.58 |
| ▸ | PBRM1 | Q86U86 | 1/20 | 0.58 |
| ▸ | GRIK1 | P39086 | 6/20 | 0.57 |
| ▸ | TTR | P02766 | 2/20 | 0.56 |
| ▸ | AKR1C3 | P42330 | 2/20 | 0.56 |
| ▸ | LMNA | P02545 | 2/20 | 0.56 |
| ▸ | MAPT | P10636 | 2/20 | 0.56 |
| ▸ | MEN1 | O00255 | 1/20 | 0.56 |
| ▸ | USP2 | O75604 | 1/20 | 0.56 |
| ▸ | MT-CO2 | P00403 | 1/20 | 0.56 |
| ▸ | PLA2G1B | P04054 | 1/20 | 0.56 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.56 |
| ▸ | PGR | P06401 | 1/20 | 0.56 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.56 |
| ▸ | HTR1A | P08908 | 1/20 | 0.56 |
| ▸ | ADRA2A | P08913 | 1/20 | 0.56 |
| ▸ | ADORA3 | P0DMS8 | 1/20 | 0.56 |
| ▸ | AR | P10275 | 1/20 | 0.56 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL11603203 | 0.92 | FABP4 (0.69) | FABP4FABP3FTOPBRM1GRIK1 | |
| Lobenzarit SCHEMBL187951 | 0.92 | GRIK1 (0.63) | FABP4FABP3FTOPBRM1GRIK1 | |
| Lobenzarit SCHEMBL30753983 | 0.92 | GRIK1 (0.63) | FABP4FABP3FTOPBRM1GRIK1 | |
| Lobenzarit SCHEMBL7935 | 0.90 | GRIK1 (0.61) | FABP4FABP3FTOPBRM1GRIK1 | |
| Lobenzarit SCHEMBL29453054 | 0.90 | GRIK1 (0.61) | FABP4FABP3FTOPBRM1GRIK1 | |
| Lobenzarit SCHEMBL9621335 | 0.90 | GRIK1 (0.61) | FABP4FABP3FTOPBRM1GRIK1 | |
| Lobenzarit SCHEMBL1479150 | 0.90 | GRIK1 (0.61) | FABP4FABP3FTOPBRM1GRIK1 | |
| SCHEMBL24021599 | 0.89 | LMNA (0.62) | FABP4FABP3FTOPBRM1GRIK1 | |
| SCHEMBL16489012 | 0.89 | EGFR (0.66) | FABP4FABP3FTOPBRM1GRIK1 | |
| SCHEMBL16489008 | 0.86 | TAS2R14 (0.64) | FABP4FABP3FTOPBRM1GRIK1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1525183-A1 | INHIBITORS OF HCV NS5B POLYMERASE | Pharmacia & Upjohn Company LLC (US) | 2005-04-27 | — | — | EP | claimed |
| US-20040142993-A1 | Inhibitors of HCV NS5B polymerase | PHARMACIA & UPJOHN COMPANY | 2004-07-22 | — | — | US | claimed |
| WO-2004002940-A1 | INHIBITORS OF HCV NS5B POLYMERASE | PHARMACIA & UPJOHN COMPANY (US) | 2004-01-08 | — | — | WO | claimed |
| EP-1525183-A1 | INHIBITORS OF HCV NS5B POLYMERASE | Pharmacia & Upjohn Company LLC (US) | 2005-04-27 | — | — | EP | disclosed |
| US-20040142993-A1 | Inhibitors of HCV NS5B polymerase | PHARMACIA & UPJOHN COMPANY | 2004-07-22 | — | — | US | disclosed |
| WO-2004002940-A1 | INHIBITORS OF HCV NS5B POLYMERASE | PHARMACIA & UPJOHN COMPANY (US) | 2004-01-08 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20040142993-A1 | Inhibitors of HCV NS5B polymerase | POLRMT, POLR1E, CTDSP1 | FABP4 4112/4885FABP3 3352/4885FTO 4426/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.